Sleep Aids Market to Reach US$ 118.97 Billion by 2033, Growing at 7.8% CAG | Top Companies are Teva Pharmaceutical Industries Ltd., Merck & Co., Sanofi.

The global sleep aids market reached US$ 60.96billion in 2023, with a rise to US$ 65.20 billion in 2024, and is expected to reach US$ 118.97billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033.

Sleep aids refer to substances or devices used to help individuals fall asleep or improve the quality of their sleep. These aids can range from over-the-counter medications, such as antihistamines or melatonin, to prescription drugs like benzodiazepines or sleeping pills. Non-medication options include sleep therapy devices such as CPAP machines, white noise machines, or sleep masks, as well as behavioral approaches like cognitive behavioral therapy for insomnia (CBT-I). Sleep aids are commonly used to manage conditions such as insomnia, sleep apnea, and jet lag.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Sleep Aids Market Landscape:- https://datamintelligence.com/download-sample/sleep-aids-market?Ranjith

☛ Sleep Aids Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In September 2025, Pfizer Inc. announced a strategic collaboration with Philips Sleep & Respiratory Care to develop digital therapeutic solutions combining sleep medications with connected monitoring devices for personalized insomnia management.

✅ In August 2025, Haleon plc expanded its Unisom® product line with a new extended-release melatonin formulation, designed to support sustained sleep throughout the night without residual next-day drowsiness.

✅ In July 2025, Jazz Pharmaceuticals received FDA approval for its once-nightly oxybate formulation (Lumryz®) to treat excessive daytime sleepiness in adults with narcolepsy, improving convenience and compliance over traditional two-dose regimens.

✅ In June 2025, CVS Health introduced a nationwide pilot of its AI-driven sleep coaching platform integrating wearable data, behavioral therapy modules, and OTC supplement recommendations for chronic insomnia sufferers.

Japan: Recent Industry Developments

✅ In September 2025, Eisai Co., Ltd. launched Dayvigo® (lemborexant) in collaboration with Pfizer Japan, targeting adults with insomnia characterized by difficulties with sleep onset and maintenance. The dual orexin receptor antagonist continues to gain market share in Asia-Pacific.

✅ In August 2025, Taisho Pharmaceutical Holdings Co., Ltd. introduced a non-prescription herbal sleep aid drink containing valerian root and GABA, tailored to Japan's growing demand for natural and relaxation-based sleep products.

✅ In July 2025, Otsuka Pharmaceutical Co., Ltd. partnered with Hitachi Ltd. to develop EEG-based wearable devices for real-time monitoring of sleep quality and circadian rhythm disturbances.

✅ In May 2025, Shionogi & Co., Ltd. initiated preclinical research on a next-generation orexin agonist aimed at treating hypersomnia and sleep-wake regulation disorders, representing a novel approach beyond traditional sedative-hypnotics.

☛ Sleep Aids Market Competitive Landscape:

Teva Pharmaceutical Industries Ltd., Merck & Co., Sanofi, DeVilbiss Healthcare LLC., Pfizer Inc., SleepMed Inc., Cadwell Laboratories Inc., Compumedics Limited, Natus Medical Incorporated, GlaxoSmithKline Plc.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/sleep-aids-market?Ranjith

☛ Segments Covered in the Sleep Aids Market:

By Product: Sleep apnea devices (Positive airway pressure (PAP) devices, Facial interfaces devices, Oral devices, Adaptive servo-ventilation(ASV), Others

By Medication: Prescription drugs, Over-the-counter (OTC) drugs, Herbal remedies), Mattresses, and pillows, Others

By Disorder Type: Insomnia, Sleep Deprivation, Narcolepsy, Sleep Apnea

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Sleep Aids Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=sleep-aids-market?Ranjith

☛ Regional Analysis for Sleep Aids Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.